Upload
morris-johnson
View
349
Download
2
Tags:
Embed Size (px)
Citation preview
REBRANDING HEMP FOR THE NUTRACEUTICAL
MARKET
CANTERPENE AS A HEALTHSPAN EXTENSION
SUPPLEMENT
Original CANTERPENE concept Presented at :Canadian Hemp Trade Alliance Nov 15-17, 2010
Annual Conference Winnipeg , Manitoba , Canada
REBRAND CANADIAN HEMP AS REBRAND CANADIAN HEMP AS CANTERPENECANTERPENE
We link Canadian Hemp with the messages:
“Extend Health-span and Lifespan naturally with cannabis chemistry”
Canterpene expands functional chemistry beyond arginine and omega3’s to include cannabinoids and terpenes
NUMEROUS BIOCHEMICAL BENEFITS OF CANNABINOIDS IN HEMP
Canterpene is a source of supplemental terpenes
Many terpenes exhibit health benefits
Chemo-profiles of some cannabis varieties
Terry Grossman,M.D. Medical Director
Morris Johnson, CTO, Founder
Silas Kanning,
Co-founders of:
Lifespan Pharma Inc.
REBRANDING HEMP AS CANTERPENE MAKES SENSE FOR THE NATURAL HEALTH PRODUCT /
DSHEA FOOD SUPPLEMENT MARKETS
Hemp is undergoing a similar identity Hemp is undergoing a similar identity crisiscrisis i in the minds of many todayn the minds of many today
WE HAVE PATENTED CANTERPENE WE HAVE PATENTED CANTERPENE AS A PROPRIETARY FORMULATION AS A PROPRIETARY FORMULATION
OF MILLED HEMPSEEDOF MILLED HEMPSEED
CANADIAN HEMP IS LEGAL AND EXEMPT FROM SCHEDULE 1 REGULATION AS IT IS NEITHER HERBAL
MARIJUANA NOR SYNTHETIC THC
THIS GIVES US A MONOPOLY OVER ALL HEMP CHEMISTRY NOT SPECIFIC TO
OIL AND MEALThe only conditions under which non seed material can leave the Canadian farms are captured by the patent
Intellectual property rights can be enforced by USA and Canadian border security agents
USA government regulators prefer a captive regulated imported hemp supply that is segregated from their domestic illegal unregulated cannabis market
Our goal is to expand Canadian hemp production from 50,000 acres now to 500,000 acres within 5 years and capture 80% of the supply chain from farm to distribution of finished goods as nutraceuticals compounded with Canterpene
CANTERPENE IS A SOUND INVESTMENT INTO PERSONAL
PREVENTATIVE MEDICINE The medical marijuna market is technically illegal but its existence demonstrates the USA consumer’s willingness to pay billions of dollars for cannabis nutraceutical supplements.
The economics of growing hemp by the square mile and processing hemp by the ton deliver a product that is economical enough to be consumed in quantities sufficient to be an efficacious nutraceutical
CANTERPENE PROCESSING ALGORITHMProcessing consists of using a set of portable processing skids on the farm to:
A :cut and bale and put through a combine harvester or cut and process using a dehydration and pelleting procedure to produce an inseparable grain/biomass patent compliant mixture
B: remill to a fine powder with a Comitrol mill
C: combine with ethanol/water/orange oil solvents to crack the bioactives by sufficient agitation of a slurry
D: extract hemp oil/bioactive liquid with a decanting centrifuge and reflux extract by repeating step C to concentrate the bioactives.
E: combine oil with other ingredients and encapsulate/bottle/label/package and distribute to retailer
MSRP ~ 40.00/ BOTTLE OF 100 750 MG CAPSULES1-INGREDIENTS – COMPOSITE VALUE OF INGREDIENTS 11.00/BOTTLE = (410.00/GALLON OR 50.00/POUND) -60/GALLON -TO COST OF GROWING CROP -160/GALLON -TO BUILD AND OPERATE AND EXPAND FACILITIES AND EQUIPMENT FLEET TO CONVERT CROP IN THE FIELD TO OIL/EXTRACT/DERIVATIVES -90/GALLON -TO PHYTOCHEMICAL R&D/CLINICAL TRIALS -100/GALLON -TO OVERHEAD/TAXES/RETURN TO INVESTORS2-ENCAPSULATION/PKGING./BOTTELING /LABELING -9.00/BTL3-MARKETING -15.00/BOTTLE4-DISTRIBUTION/SHIPPING -5.00/BOTTLE AS WE SCALE UP , WE WORK EFFICIENCIES INTO EACH LINE ITEM TO PROVIDE INVESTORS WITH A PROPER RETURN ON INVESTMENT ….DETAILS IN OUR BUSINESS PLAN
THE BOTTOM LINE:25-35% TARGET RETURN ON INVESTMENT
CANTERPENE CAN HELP AS A PREVENTIVE ANTIAGING STRATEGY
Science has linked numerous compounds Science has linked numerous compounds found in Canterpene with beneficial effects found in Canterpene with beneficial effects on the diseases resulting from “normal” on the diseases resulting from “normal” agingaging
Canterpene captures much that other Canterpene captures much that other conventional hemp supplements have conventional hemp supplements have ignored…….ignored…….http://www.slideshare.net/lifespan.pharma.inc/canterpene-hemp-based-nutraceutical-formulations/download
DSHEA COMPLIANT TARGETS -Optimize the broad spectrum of Canterpene functionalities
-Add phytochemistry to enhance each functionality
-Utilize ingredients with both ethnobotanical and modern pharmacological support in peer-reviewed , published literature
-Proprietary varietal selection and agronomic production practices allow the use of the same Canterpene ingredient for several distinctly different formulations
-10 unique formulas can be combined into an individualized therapeutic program to attack a systemic problem, AGING
“Medicine without a market benefits no one”
DOES CANTERPENE HAVE A MARKET?
-Healthspan extension and lifespan optimization are new unmet needs
-Personalized /Individualized Medicine is an emerging Industry
-”Bockbuster” Pharma is migrating towards “Niche” Pharma
-Canterpene Cannabis without THC contains phyto-chemistry which scientific research indicates would make it a
useful food supplement for:
“personalized management of Aging “
ANTIAGING IS AN ENORMOUS MARKET
76 million baby boomers in the US
6 million “boomies” in Canada
Boomers now 48 – 64 and have begun to experience the “aging process” firsthand
This generation has redefined each stage of their lives and is currently redefining aging
BOOMERS REGARD AGING AS A DISEASE …
… THAT AFFECTS EVERYONE
… AND IS 100 PERCENT FATAL
AGING , A SYSTEMIC DEGENERATIVE SYNDROME WITH MULTIPLE THERAPEUTIC TARGETS HTTP://WWW.YOUTUBE.COM/WATCH?V=GHVXW2EE3-A
THE TWO PILLARS OF HEALTH
Prevention EarlyDetection
The name of the game is to “beat this clock”
CANTERPENE BENEFITS EVERYONE IN THE SUPPLY
CHAIN FROM THE FARMER TO THE CONSUMER
GOOD SCIENCE WITHOUT A GOOD SCIENCE WITHOUT A METHOD TO COMMERCIALIZE IT METHOD TO COMMERCIALIZE IT
WILL NOT BENEFIT ANYONEWILL NOT BENEFIT ANYONE